Lee, Danner & Bass’s Organon & Co OGN Stock Holding History

Lee, Danner & Bass’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,767	Closed	-$217K	–	198
2022 Q4	$217K	Buy	+7,767	New	+$199K	0.02%	187
2022 Q3	–	Sell	-8,661	Closed	-$292K	–	197
2022 Q2	$292K	Buy	8,661 +634	+8%	+$22.2K	0.03%	177
2022 Q1	$280K	Sell	8,027 -399	-5%	-$13.6K	0.02%	180
2021 Q4	$257K	Sell	8,426 -2,777	-25%	-$90.4K	0.02%	182
2021 Q3	$367K	Buy	11,203 +198	+2%	+$6.33K	0.03%	164
2021 Q2	$333K	Buy	+11,005	New	+$362K	0.03%	169

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lee, Danner & Bass's OGN Position: Q1 2023 in Review

Lee, Danner & Bass sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 7,767 shares — an estimated $217K sold.

Lee, Danner & Bass first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $367K in Q3 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Lee, Danner & Bass reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Lee, Danner & Bass sold 7,767 Organon & Co shares in Q1 2023, an estimated $217K.
Lee, Danner & Bass first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
Lee, Danner & Bass's Organon & Co position peaked at $367K in Q3 2021.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Lee, Danner & Bass's 13F filing for Q1 2023, filed 2 May 2023.